Strategic partnership Mellitus Health has an exclusive distribution partner in Semler Scientific for Insulin Insights in the United States and Puerto Rico, presenting a direct channel for sales expansion and co-marketing opportunities.

Clinical efficacy An FDA-cleared and CE-registered solution that integrates with major glucometers and workflows, with demonstrated HbA1c reduction in a real-world study, supporting compelling value propositions for payer and provider clients.

Tech integration Software supports all eight standard insulin regimens and various insulins, and interoperates with existing clinical systems, enabling a broad addressable market among diabetes care teams seeking decision support automation.

Market reach Small to mid-sized diabetes care organizations and clinics with limited insulin dosing support represent a scalable target, leveraging Mellitus Health’s lean team and established partnerships to accelerate penetration.

Brand credibility Longstanding clinical research heritage from Mayer B. Davidson and recognition such as Best Abstract awards enhance credibility for sales conversations with clinicians, administrators, and potential strategic investors.